Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches

Read original: arXiv:2410.00709 - Published 10/2/2024 by Xuefeng Liu, Songhao Jiang, Xiaotian Duan, Archit Vasan, Chong Liu, Chih-chan Tien, Heng Ma, Thomas Brettin, Fangfang Xia, Ian T. Foster and 1 other
Total Score

0

Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Binding affinity prediction is a critical task in drug discovery and computational biology
  • This paper reviews conventional and machine learning-based approaches for binding affinity prediction
  • It covers key datasets and benchmarks, conventional methods, and the latest advancements in ML-based techniques

Plain English Explanation

Binding affinity refers to how strongly a drug molecule binds to its target protein in the body. Accurately predicting binding affinity is crucial for developing effective new drugs. This paper provides an overview of the different approaches used for binding affinity prediction.

Traditional computational methods for binding affinity prediction rely on physics-based models that simulate the interactions between drug molecules and proteins. While these methods have been useful, they can be complex and time-consuming. In recent years, machine learning techniques have emerged as a powerful alternative for binding affinity prediction.

Machine learning models can learn patterns from large datasets of known drug-protein interactions and use that knowledge to make predictions about new molecules. These ML-based methods have shown improved accuracy and efficiency compared to conventional approaches.

The paper also discusses the key datasets and benchmarks used to train and evaluate binding affinity prediction models, as well as emerging hybrid approaches that combine classical physics-based simulations with machine learning.

Technical Explanation

The paper begins by highlighting the importance of binding affinity prediction in drug discovery, as it helps researchers identify promising drug candidates and optimize their properties.

It then provides an overview of the key datasets and benchmarks used in this field, such as the CSAR and PDBbind datasets, which contain experimental measurements of binding affinities for large numbers of protein-ligand complexes. These datasets serve as valuable resources for training and evaluating both conventional and machine learning-based models.

The paper then reviews the conventional, physics-based approaches for binding affinity prediction, such as molecular docking, free energy calculations, and knowledge-based scoring functions. These methods aim to simulate the underlying physical and chemical interactions that govern binding, but can be computationally intensive and require careful parameterization.

In contrast, the paper describes how machine learning techniques can learn predictive models directly from data, without relying on explicit physical modeling. It covers the application of various ML architectures, including classical regression models, deep neural networks, and graph neural networks, to the binding affinity prediction task.

The paper highlights the advantages of ML-based methods, such as their ability to capture complex nonlinear relationships, their efficiency in making predictions, and their potential for incorporating diverse data sources beyond just structural information. It also discusses emerging hybrid approaches that combine classical simulations with machine learning to leverage the strengths of both paradigms.

Critical Analysis

The paper provides a comprehensive overview of the field of binding affinity prediction, covering both conventional and state-of-the-art machine learning-based techniques. It acknowledges the limitations of traditional physics-based methods, such as their computational complexity and the need for careful parameterization.

At the same time, the paper recognizes that machine learning models are not a panacea and may face challenges of their own. For example, the performance of ML models can be heavily dependent on the quality and diversity of the training data available. The paper suggests that further research is needed to address data sparsity and imbalance issues in binding affinity datasets.

Additionally, the paper notes that while ML-based methods have shown promising results, there is still room for improvement in terms of their interpretability and ability to generalize to novel chemical spaces. Developing more transparent and robust ML models for binding affinity prediction remains an active area of research.

The paper also highlights the emergence of hybrid approaches that combine classical simulations with machine learning, which may offer a way to leverage the strengths of both paradigms. However, the implementation and optimization of such hybrid models is an ongoing challenge that requires further exploration.

Conclusion

This paper provides a comprehensive review of the field of binding affinity prediction, tracing the evolution from conventional, physics-based methods to the latest advancements in machine learning-based techniques. It underscores the critical importance of accurate binding affinity prediction in drug discovery and computational biology, and discusses the key datasets, benchmarks, and methodological approaches in this domain.

The paper's in-depth coverage of both conventional and ML-based methods, as well as its discussion of emerging hybrid approaches, offers valuable insights for researchers and practitioners working in this field. By highlighting the strengths, limitations, and future directions of binding affinity prediction, the paper helps to guide the continued development of more accurate, efficient, and interpretable computational tools for drug discovery and design.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches
Total Score

0

New!Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches

Xuefeng Liu, Songhao Jiang, Xiaotian Duan, Archit Vasan, Chong Liu, Chih-chan Tien, Heng Ma, Thomas Brettin, Fangfang Xia, Ian T. Foster, Rick L. Stevens

Protein-ligand binding is the process by which a small molecule (drug or inhibitor) attaches to a target protein. The binding affinity, which refers to the strength of this interaction, is central to many important problems in bioinformatics such as drug design. An extensive amount of work has been devoted to predicting binding affinity over the past decades due to its significance. In this paper, we review all significant recent works, focusing on the methods, features, and benchmark datasets. We have observed a rising trend in the use of traditional machine learning and deep learning models for predicting binding affinity, accompanied by an increasing amount of data on proteins and small drug-like molecules. While prediction results are constantly improving, we also identify several open questions and potential directions that remain unexplored in the field. This paper could serve as an excellent starting point for machine learning researchers who wish to engage in the study of binding affinity, or for anyone with general interests in machine learning, drug discovery, and bioinformatics.

Read more

10/2/2024

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction
Total Score

0

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

Nikolai Schapin, Carles Navarro, Albert Bou, Gianni De Fabritiis

Binding affinity optimization is crucial in early-stage drug discovery. While numerous machine learning methods exist for predicting ligand potency, their comparative efficacy remains unclear. This study evaluates the performance of classical tree-based models and advanced neural networks in protein-ligand binding affinity prediction. Our comprehensive benchmarking encompasses 2D models utilizing ligand-only RDKit embeddings and Large Language Model (LLM) ligand representations, as well as 3D neural networks incorporating bound protein-ligand conformations. We assess these models across multiple standard datasets, examining various predictive scenarios including classification, ranking, regression, and active learning. Results indicate that simpler models can surpass more complex ones in specific tasks, while 3D models leveraging structural information become increasingly competitive with larger training datasets containing compounds with labelled affinity data against multiple targets. Pre-trained 3D models, by incorporating protein pocket environments, demonstrate significant advantages in data-scarce scenarios for specific binding pockets. Additionally, LLM pretraining on 2D ligand data enhances complex model performance, providing versatile embeddings that outperform traditional RDKit features in computational efficiency. Finally, we show that combining 2D and 3D model strengths improves active learning outcomes beyond current state-of-the-art approaches. These findings offer valuable insights for optimizing machine learning strategies in drug discovery pipelines.

Read more

7/30/2024

🔮

Total Score

0

Improved prediction of ligand-protein binding affinities by meta-modeling

Ho-Joon Lee, Prashant S. Emani, Mark B. Gerstein

The accurate screening of candidate drug ligands against target proteins through computational approaches is of prime interest to drug development efforts. Such virtual screening depends in part on methods to predict the binding affinity between ligands and proteins. Many computational models for binding affinity prediction have been developed, but with varying results across targets. Given that ensembling or meta-modeling methods have shown great promise in reducing model-specific biases, we develop a framework to integrate published force-field-based empirical docking and sequence-based deep learning models. In building this framework, we evaluate many combinations of individual base models, training databases, and several meta-modeling approaches. We show that many of our meta-models significantly improve affinity predictions over base models. Our best meta-models achieve comparable performance to state-of-the-art deep learning tools exclusively based on structures, while allowing for improved database scalability and flexibility through the explicit inclusion of features such as physicochemical properties or molecular descriptors. Overall, we demonstrate that diverse modeling approaches can be ensembled together to gain improvement in binding affinity prediction.

Read more

5/21/2024

🧠

Total Score

0

A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery

L. Domingo, M. Chehimi, S. Banerjee, S. He Yuxun, S. Konakanchi, L. Ogunfowora, S. Roy, S. Selvaras, M. Djukic, C. Johnson

The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite these advances, existing models encounter issues related to convergence stability and prediction accuracy. This paper introduces a novel hybrid quantum-classical deep learning model tailored for binding affinity prediction in drug discovery. Specifically, the proposed model synergistically integrates 3D and spatial graph convolutional neural networks within an optimized quantum architecture. Simulation results demonstrate a 6% improvement in prediction accuracy relative to existing classical models, as well as a significantly more stable convergence performance compared to previous classical approaches.

Read more

9/4/2024